Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Recruiting 6Active not recruiting 5Completed 2

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Gynecologic 1

Conditions

Breast Neoplasms 3Advanced Breast Cancer 2ER+ HER2- Advanced Breast Cancer 1

Interventions

Specimen Handling 481pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 239Paclitaxel 226Gemcitabine 222Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 165Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × AZD9833 × 1 year × Clear all
NCT07195227 2026-05-29

CADILLAC

MedSIR

Phase 2 Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT05952557 2026-05-28

CAMBRIA-2

AstraZeneca

Phase 3 Recruiting
5,500 enrolled
Breast

Breast Neoplasms

NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting
500 enrolled
Breast

Advanced Breast Cancer

NCT06188520 2026-05-11

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting
564 enrolled
BreastGynecologic

ER+ HER2- Advanced Breast Cancer

NCT05774951 2026-05-08

CAMBRIA-1

AstraZeneca

Phase 3 Recruiting
4,300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡